Eton Pharmaceuticals, Inc.
ETON
$17.28
-$0.18-1.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.44% | -162.88% | -195.37% | 120.62% | -274.97% |
| Total Depreciation and Amortization | -0.79% | 185.35% | 27.70% | -0.36% | 19.23% |
| Total Amortization of Deferred Charges | -73.47% | -70.18% | 2,428.21% | -33.90% | 136.00% |
| Total Other Non-Cash Items | 39.30% | 176.88% | 18.01% | -12.17% | -2.03% |
| Change in Net Operating Assets | 154,475.00% | 99.83% | -283.51% | -58.99% | 213.62% |
| Cash from Operations | 280.81% | 373.20% | -125.91% | 135.22% | 150.75% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -100.00% | -95.23% | -- | -100.00% | 2,314.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -98.83% | 8,820.00% | -78.24% | 42.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 220.41% | 146.65% | -307.44% | 147.06% | 121.95% |